Daymark Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Daymark Wealth Partners's BMY Position: Q3 2026 in Review
Daymark Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q3 2026, selling an estimated $135K and leaving 82,906 shares worth $5.17M. The position accounts for 0.12% of the portfolio, ranked #143.
Daymark Wealth Partners first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $5.53M in Q1 2026. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Daymark Wealth Partners held 82,906 shares of Bristol-Myers Squibb worth $5.17M as of Q3 2026.
- Daymark Wealth Partners sold 2,132 Bristol-Myers Squibb shares in Q3 2026, an estimated $135K.
- Bristol-Myers Squibb made up 0.12% of Daymark Wealth Partners's portfolio in Q3 2026, its #143 holding.
- Daymark Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
- Daymark Wealth Partners's Bristol-Myers Squibb position peaked at $5.53M in Q1 2026.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Daymark Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.